Mitotic kinesin inhibitors
US7504405B2 · kind B2 · utility
4Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 6, 2005 |
| Grant date | Mar 17, 2009 |
| Priority date | — |
| Expiry date | Apr 6, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D239/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds that are useful for treating cellular proliferative diseases, for treating disorders mediated, at least in part, by KSP, and for inhibiting KSP. The invention also related to pharmaceutical compositions comprising such compounds, methods of treating cancer by the administration of such compositions, and processes for the preparation of the compounds. Compounds of the invention have the following formula:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.